---
schema_version: "secwatch.filing_event.v1"
accession: "0001157523-22-001106"
form_type: "8-K"
ticker: "CVSA"
cik: "0000730464"
company_name: "Covista Inc."
filed_at: "2022-08-11T23:59:59+00:00"
generated_at: "2026-06-24T01:12:08.806343+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Adtalem Q4 revenue +61.6% to $361.2M; FY2022 adj. EPS $3.24 (+40% YoY); FY2023 guidance $3.95-$4.20

## Summary
- Q4 revenue $361.2M (+61.6% YoY); GAAP EPS $0.18 flat; adjusted EPS $1.31 vs $0.48 YoY.
- FY2022 GAAP EPS $6.57; adjusted EPS $3.24, up 40% YoY; adjusted EBITDA margin 24.0% vs 22.4%.
- Gross debt reduced by $394.1M in Q4 (31.4%); balance sheet strengthened.
- FY2023 guidance: revenue $1.38B-$1.45B; adjusted EPS $3.95-$4.20.
- Chamberlain enrollment -5.8% YoY; Walden enrollment -9.5%; Medical/Vet enrollment +3.5%.

## SEC filing metadata
- accession: 0001157523-22-001106
- form_type: 8-K
- ticker: CVSA
- cik: 0000730464
- company_name: Covista Inc.
- filed_at: 2022-08-11T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/730464/000115752322001106/0001157523-22-001106-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/730464/000115752322001106/a52809088.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001157523-22-001106
- JSON: https://secwatch.observer/filing/0001157523-22-001106.json
- Plain text: https://secwatch.observer/filing/0001157523-22-001106.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.